drugset / Trial / NCT00393497
A Pilot Study of VEGF Inhibition in Patients With Lymphedema Following Breast Cancer Treatment
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the effectiveness of bevacizumab in women with lymphedema as a result of previous treatment for breast cancer.
Timeline
- Start
- 2007-04
- Primary completion
- 2009-10
- Completion
- 2011-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bevacizumab | Monoclonal antibody | 15 mg/kg | Intravenous |